Invention Grant
- Patent Title: HMG-CoA reductase inhibitors
- Patent Title (中): HMG-CoA还原酶抑制剂
-
Application No.: US11789335Application Date: 2007-04-24
-
Publication No.: US07659281B2Publication Date: 2010-02-09
- Inventor: Philip D. Stein , Steven P. Seitz , David J. Carini , Yan Shi , Jeffrey A. Robl , Jay A. Markwalder , Chunhong He
- Applicant: Philip D. Stein , Steven P. Seitz , David J. Carini , Yan Shi , Jeffrey A. Robl , Jay A. Markwalder , Chunhong He
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Burton Rodney
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/44 ; C07D221/18 ; C07D221/22
Abstract:
Compounds are provided of the following structure are HMG CoA reductase inhibitors and thus are active in inhibiting cholesterol biosynthesis, modulating blood serum lipids, for example, lowering LDL cholesterol and/or increasing HDL cholesterol, and treating hyperlipidemia and dyslipidemia, hypercholesterolemia, hypertriglyceridemia and atherosclerosis wherein variables A and B are defined herein.
Public/Granted literature
- US20070249583A1 HMG-CoA reductase inhibitors Public/Granted day:2007-10-25
Information query
IPC分类:
